Literature DB >> 33546293

The Perspectives of Fertility Preservation in Women with Endometrial Cancer.

Jure Knez1,2, Leyla Al Mahdawi2, Iztok Takač1,2, Monika Sobočan1,2.   

Abstract

Endometrial cancer is the most common gynecological cancer in developed countries. The disease is diagnosed with increasing frequency in younger women, commonly also in their reproductive age. The standard treatment of endometrial cancer is surgical in the form of hysterectomy and bilateral salpingo-oophorectomy, and this precludes future fertility in younger women. The current challenge is to identify the group of women with endometrial cancer and low-risk features that would benefit from more conservative treatment options. More focus in management needs to be aimed towards the preservation of quality of life, without jeopardizing oncological outcomes. In this review, we analyze the current approaches to identification of women for conservative management and evaluate the success of different medical options for treatment and surgical techniques that are fertility sparing. We also elaborate on the future perspectives, focusing on the incorporation of molecular characterization of endometrial cancer to fertility preservation algorithms. Future studies should focus specifically on identifying reliable clinical and molecular predictive markers in this group of young women. With improved knowledge and better risk assessment, the precision medicine is the path towards improved understanding of the disease and possibly widening the group of women that could benefit from treatment methods preserving their fertility.

Entities:  

Keywords:  endometrial cancer; fertility sparing; molecular classification; quality of life; reproductive function; young women

Year:  2021        PMID: 33546293      PMCID: PMC7913307          DOI: 10.3390/cancers13040602

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  78 in total

1.  Practice Bulletin No. 149: Endometrial cancer.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-04       Impact factor: 7.661

2.  Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series.

Authors:  Francesca Falcone; Nicola Normanno; Nunzia S Losito; Giosuè Scognamiglio; Riziero Esposito Abate; Nicoletta Chicchinelli; Gennaro Casella; Giuseppe Laurelli; Cono Scaffa; Stefano Greggi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2019-07-13       Impact factor: 2.435

3.  Conservative surgical management of stage IA endometrial carcinoma for fertility preservation.

Authors:  Ivan Mazzon; Giacomo Corrado; Valeria Masciullo; Daniela Morricone; Gabriella Ferrandina; Giovanni Scambia
Journal:  Fertil Steril       Date:  2009-08-22       Impact factor: 7.329

4.  A patient group at negligible risk of para-aortic lymph node metastasis in endometrial cancer.

Authors:  Yukiharu Todo; Kazuhira Okamoto; Sho Takeshita; Satoko Sudo; Hidenori Kato
Journal:  Gynecol Oncol       Date:  2016-01-26       Impact factor: 5.482

5.  Direct Comparison of Logistic Regression and Recursive Partitioning to Predict Lymph Node Metastasis in Endometrial Cancer.

Authors:  Martin Koskas; Dominique Luton; Olivier Graesslin; Emmanuel Barranger; Françoise Clavel-Chapelon; Bassam Haddad; Emile Darai; Roman Rouzier
Journal:  Int J Gynecol Cancer       Date:  2015-07       Impact factor: 3.437

6.  Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.

Authors:  Takeshi Makabe; Eri Arai; Takuro Hirano; Nanako Ito; Yukihiro Fukamachi; Yoriko Takahashi; Akira Hirasawa; Wataru Yamagami; Nobuyuki Susumu; Daisuke Aoki; Yae Kanai
Journal:  Carcinogenesis       Date:  2019-07-04       Impact factor: 4.944

7.  Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.

Authors:  Maria Teresa Vietri; Giovanna D'Elia; Gemma Caliendo; Amelia Casamassimi; Alessandro Federico; Luana Passariello; Michele Cioffi; Anna Maria Molinari
Journal:  Med Oncol       Date:  2021-01-23       Impact factor: 3.064

Review 8.  Clinical actionability of molecular targets in endometrial cancer.

Authors:  Mary Ellen Urick; Daphne W Bell
Journal:  Nat Rev Cancer       Date:  2019-08-06       Impact factor: 60.716

9.  Integrated genomic characterization of endometrial carcinoma.

Authors:  Cyriac Kandoth; Nikolaus Schultz; Andrew D Cherniack; Rehan Akbani; Yuexin Liu; Hui Shen; A Gordon Robertson; Itai Pashtan; Ronglai Shen; Christopher C Benz; Christina Yau; Peter W Laird; Li Ding; Wei Zhang; Gordon B Mills; Raju Kucherlapati; Elaine R Mardis; Douglas A Levine
Journal:  Nature       Date:  2013-05-02       Impact factor: 49.962

Review 10.  Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review.

Authors:  Jing Wei; Weiyuan Zhang; Limin Feng; Wanli Gao
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

View more
  2 in total

Review 1.  The Advance and Correlation of KRAS Mutation With the Fertility-Preservation Treatment of Endometrial Cancer in the Background of Molecular Classification Application.

Authors:  KeXuan Yu; Yiqin Wang
Journal:  Pathol Oncol Res       Date:  2021-12-16       Impact factor: 3.201

2.  Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy.

Authors:  Junyu Chen; Dongyan Cao; Jiaxin Yang; Mei Yu; Huimei Zhou; Ninghai Cheng; Jinhui Wang; Ying Zhang; Peng Peng; Keng Shen
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.